Cargando…

The predictive value and response to immunosuppressive therapy of IgA nephropathy patients with crescents in a large retrospective Chinese cohort

BACKGROUND: The prognostic value and response to immunosuppressive therapy (IST) of patients with crescents in the different backgrounds of pathological presentations in immunoglobulin A nephropathy (IgAN) is unclear. METHODS: A total of 1262 IgAN patients were enrolled. Crescents (C, 0/1/2), fibrin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yingman, Shi, Sufang, Zhou, Xujie, Liu, Lijun, Lv, Jicheng, Zhu, Li, Wang, Suxia, Zhang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689141/ https://www.ncbi.nlm.nih.gov/pubmed/38046023 http://dx.doi.org/10.1093/ckj/sfad134

Ejemplares similares

Complement Activation Is Associated With Crescents in IgA Nephropathy
por: Wang, Zi, et al.
Publicado: (2021)

The Role of Complement in Microangiopathic Lesions of IgA Nephropathy
por: Li, Jingyi, et al.
Publicado: (2022)

Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
por: Dong, Yaping, et al.
Publicado: (2023)

A validation study of crescents in predicting ESRD in patients with IgA nephropathy
por: Zhang, Xiaoyan, et al.
Publicado: (2018)

Zonulin, as a marker of intestinal permeability, is elevated in IgA nephropathy and IgA vasculitis with nephritis
por: Li, Qianqian, et al.
Publicado: (2022)

Retrospective analysis of crescent score in clinical prognosis of IgA nephropathy
por: Chen, Ying, et al.
Publicado: (2022)

Increased plasma sVCAM-1 is associated with severity in IgA nephropathy
por: Zhu, Li, et al.
Publicado: (2013)

Clinical and pathological characteristics in elderly patients with IgA nephropathy
por: Zhang, Yongji, et al.
Publicado: (2023)

Crescents and IgA Nephropathy: A Delicate Marriage
por: Trimarchi, Hernán, et al.
Publicado: (2022)

Nomogram for the prediction of crescent formation in IgA nephropathy patients: a retrospective study
por: Lin, Zaoqiang, et al.
Publicado: (2023)

Urinary CXCL1: A Novel Predictor of IgA Nephropathy Progression
por: Zhao, Yanfeng, et al.
Publicado: (2015)

Severe Adverse Effects Associated With Corticosteroid Treatment in Patients With IgA Nephropathy
por: Cai, Qingqing, et al.
Publicado: (2017)

TWEAK/Fn14 system and crescent formation in IgA nephropathy
por: Sasaki, Yohei, et al.
Publicado: (2015)

Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?
por: Ring, Troels, et al.
Publicado: (2015)

Clinical outcomes of IgA nephropathy patients with different proportions of crescents
por: Zhang, Wang, et al.
Publicado: (2017)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Plasma Soluble Urokinase Receptor Level Is Correlated with Podocytes Damage in Patients with IgA Nephropathy
por: Zhao, Yanfeng, et al.
Publicado: (2015)

Glomerular C4d Deposition and Kidney Disease Progression in IgA Nephropathy: A Systematic Review and Meta-analysis
por: Jiang, Yuanyuan, et al.
Publicado: (2021)

A novel clinical−radiomic nomogram for the crescent status in IgA nephropathy
por: Qin, Xiachuan, et al.
Publicado: (2023)

Synergistic Effect of Mesangial Cell-Induced CXCL1 and TGF-β1 in Promoting Podocyte Loss in IgA Nephropathy
por: Zhu, Li, et al.
Publicado: (2013)

Crescents proportions above 10% are associated with unfavorable kidney outcomes in IgA nephropathy patients with partial crescent formation
por: Di, Dingxin, et al.
Publicado: (2023)

De-Novo Focal Crescentic IgA Nephropathy in a Renal Allograft Recipient
por: Ramasamy, Ashok, et al.
Publicado: (2019)

Case Report: A Pathogenic Missense Variant of WT1 Cosegregates With Proteinuria in a Six-Generation Chinese Family With IgA Nephropathy
por: Li, Qianqian, et al.
Publicado: (2022)

Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features
por: Cambier, Alexandra, et al.
Publicado: (2018)

Crescents in IgA nephropathy: making the step from prognostic risk factor to therapy target
por: Stefan, Gabriel
Publicado: (2023)

Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
por: Zan, Jincan, et al.
Publicado: (2022)

The Diagnostic Conundrum of Glomerular Crescents With IgA Deposits
por: Kitamura, Mineaki, et al.
Publicado: (2022)

The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study
por: Liang, Mengjun, et al.
Publicado: (2022)

New-onset crescent IgA nephropathy following the CoronaVac vaccine: A case report
por: Ran, Enrong, et al.
Publicado: (2022)

The Presence of ANCA in IgA Crescentic Nephropathy Does Not Lead to Worse Prognosis with Intensive Rescue Treatment
por: Agraz, Irene, et al.
Publicado: (2022)

Propensity of IgA to self-aggregate via tailpiece cysteine-471 and treatment of IgA nephropathy using cysteamine
por: Xie, Xinfang, et al.
Publicado: (2021)

The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
por: Zhao, Na, et al.
Publicado: (2012)

Plasma uric acid level indicates tubular interstitial leisions at early stage of IgA nephropathy
por: Zhou, Jingjing, et al.
Publicado: (2014)

Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
por: Kim, Min Jeong, et al.
Publicado: (2016)

Serum Soluble CD89-IgA Complexes Are Elevated in IgA Nephropathy without Immunosuppressant History
por: Wu, Haiting, et al.
Publicado: (2020)

Efficacy and safety of sequential immunosuppressive treatment for severe IgA nephropathy: A retrospective study
por: Luo, Mian-Na, et al.
Publicado: (2023)

Complete remission of nephrotic syndrome and acute kidney injury in crescentic IgA nephropathy: Role of mycophenolate sodium
por: Bhandari, D., et al.
Publicado: (2016)

Coexistence of atypical hemolytic uremic syndrome and crescentic IgA nephropathy treated with eculizumab: a case report
por: Matsumura, Daisuke, et al.
Publicado: (2016)

Crescent IgA Nephropathy and its association with anti-neutrophil cytoplasm antibody: what do we know?
por: Zamoner, Welder, et al.
Publicado: (2022)

Successful treatment of nephrotic syndrome due to pregnancy-related crescentic IgA nephropathy: a case report
por: Shima, Hisato, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_idpffc8pr0iotvd07m9n7hbd46